Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tuberculosis in Enclosed Populations.

Sorana Segal-Maurer1,2

  • 1The Dr. James J. Rahal Jr. Division of Infectious Diseases, NewYork-Presbyterian/Queens, Flushing, NY 11355.

Microbiology Spectrum
|April 1, 2017
PubMed
Summary

Tuberculosis (TB) spreads effectively indoors in congregate settings, fueled by factors like HIV and travel. Effective TB control requires identifying infectious patients, isolation, environmental measures, and treatment for active and latent TB infection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Subcutaneous Lenacapavir in People With Multidrug-Resistant HIV-1: 156 Week Results of the CAPELLA Study.

Open forum infectious diseases·2025
Same author

Treatment patterns, health care resource utilization, and costs of heavily treatment-experienced people with HIV in the United States.

Journal of managed care & specialty pharmacy·2025
Same author

Efficacy and Safety of Bictegravir Plus Lenacapavir: 48-Week Outcomes in People With HIV-1 Who Are Virologically Suppressed on Complex Antiretroviral Regimens at Baseline.

Open forum infectious diseases·2025
Same author

Efficacy, safety, and pharmacokinetics of lenacapavir oral bridging when subcutaneous lenacapavir cannot be administered.

AIDS (London, England)·2025
Same author

Resistance Analyses in Heavily Treatment-Experienced People With HIV Treated With the Novel HIV Capsid Inhibitor Lenacapavir After 2 Years.

The Journal of infectious diseases·2025
Same author

Efficacy and Safety of Switching to Daily Bictegravir Plus Lenacapavir From a Complex HIV Treatment Regimen: A Randomized, Open-Label, Multicenter Phase 2 Study (ARTISTRY-1).

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2024

Area of Science:

  • Public Health
  • Infectious Disease Epidemiology
  • Environmental Health

Background:

  • Tuberculosis (TB) transmission is highly efficient in indoor, close-contact environments.
  • Congregate settings like healthcare facilities, shelters, and transportation hubs are high-risk for TB outbreaks.
  • Factors such as the HIV epidemic, global travel, and socio-economic instability exacerbate TB spread.

Purpose of the Study:

  • To outline organized approaches for controlling tuberculosis transmission.
  • To emphasize the need for risk assessment and tailored control strategies in diverse settings.
  • To highlight the importance of comprehensive efforts in reducing the global TB burden.

Main Methods:

  • Review of established TB control strategies and guidelines.

Related Experiment Videos

  • Analysis of factors contributing to TB outbreaks.
  • Emphasis on risk assessment for tailoring interventions in various environments.

    • Main Results:

    • Effective TB control necessitates a high index of suspicion for early identification.
    • Isolation of contagious patients and implementation of environmental controls are critical.
    • Personal protective equipment (PPE) use, guided by risk assessment, is essential.

    Conclusions:

    • Comprehensive TB control requires coordinated local, regional, national, and international efforts.
    • Identifying active TB cases, ensuring treatment completion, and managing latent TB infection are paramount.
    • Tailoring control measures to specific settings is crucial for reducing TB burden and transmission.